Safety and Efficacy of Paclitaxel Liposome Arterial Infusion Combined With Systemic Therapy for Second-Line Treatment of Advanced Liver Cancer
Clinical trial NCT07282509 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07282509
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-23
- Primary completion
- 2028-06-26
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.